[1]黄培新, 王娜, 钱俊华,等. 江苏省海门市原发性肝癌队列随访结果分析. 中华流行病学杂志, 2017, 38(10):1376-1379. [2]Wang C, Yang L, Liang Z, et al. Long-term survival and prognostic factors of pulmonary metastasectomy in liver cancer: a systematic review and meta-analysis.World J Surg, 2018, 42(7):2153-2163. [3]Engstrand J, Nilsson H, Jansson A, et al. Fate of necrotic volume after microwave ablation of multiple liver metastases.Hepatogastroenterology, 2015, 62(137):108-110. [4]Li M, Li Z, Yu X, et al. Percutaneous radio-frequency ablation of hepatocellular carcinoma adjacent to the gastrointestinal tract.Int J Hyperthermia, 2016, 32(6):600-606. [5]Dou JP, Yu J,Yang XH, et al. Outcomes of microwave ablation for hepatocellular carcinoma adjacent to large vessels: A propensity score analysis. Oncotarget, 2017, 8(17):28758-28768. [6]钟丽云, 蒋天安, 赵齐羽,等. 影像融合超声造影技术对常规超声及超声造影显示不清肝癌的诊治价值. 中华超声影像学杂志, 2015, 24(11):963-967. [7]中华人民共和国卫生部. 原发性肝癌诊疗规范(2011年版). 中华肝脏病杂志, 2012, 20(6):929-946. [8]Zaidi N, Okoh A, Yigitbas H, et al. Laparoscopic microwave thermosphere ablation of malignant liver tumors: An analysis of 53 cases.J Surg Oncol, 2016, 113(2):130-134. [9]Liu F, Yu X, Cheng Z, et al. Risk factors for hemoglobinuria after ultrasonography-guided percutaneous microwave ablation for large hepatic cavernous hemangiomas. Oncotarget, 2018, 9(39):25708-25713. [10]张立洪, 张传永, 戴新征,等. 术后复发性小肝癌微波消融与再次手术切除的疗效比较. 中华普通外科杂志, 2015, 30(8):631-634. [11]柳昂, 许伟, 徐浩,等. 肝动脉化学治疗栓塞联合超声引导下微波消融治疗特殊部位肝癌疗效观察. 中华肝脏病杂志, 2017, 25(12):914-919. [12]Shi Y, Liu X, Luo Z, et al. The impact of microbubble-enhanced therapeutic ultrasound combined with prothrombin on microwave ablation in the rabbit liver. Med Ultrason, 2016, 18(4):438-445. [13]Kim TK, Khalili K, Jang HJ . Local ablation therapy with contrast-enhanced ultrasonography for hepatocellular carcinoma: a practical review. Ultrasonography, 2015, 34(4):235-245. [14]Zimmermann H, Rübenthaler J, Paprottka P, et al. Feasability of contrast-enhanced ultrasound with image fusion of CEUS and MS-CT for endovascular grafting in infrarenal abdominal aortic aneurysm in a single patient. Clin Hemorheol Microcirc, 2016, 64(4):711-719. [15]Feng X, Linghu E, Chai N, et al. New treatment of the pancreatic cystic neoplasm: endoscopic ultrasonography-guided radiofrequency ablation combined with lauromacrogol ablation.Turk J Gastroenterol, 2017, 29(1):101-104. [16]Sebek J,Albin N,Bortel R, et al. Sensitivity of microwave ablation models to tissue biophysical properties: A first step toward probabilistic modeling and treatment planning. Med Phys, 2016, 43(5):2649-2661. [17]Assmar M, Yeganeh S, Mansourghanaei F, et al. Combined evaluation of AFP, CA15-3, CA125, CA19-9, and CEA tumor markers in patients with hepatitis B and C. Iran J of Public Health, 2016, 45(12):1645-1651. [18]Liu H, Xu Y, Xiang J, et al. Targeting alpha-fetoprotein (AFP)-MHC complex with CAR T cell therapy for liver cancer. Clin Cancer Res, 2016, 23(2):478-488. [19]Bo XW, Xu HX, Guo LH, et al. Ablative safety margin depicted by fusion imaging with post-treatment contrast-enhanced ultrasound and pretreatment CECT/CEMRI after radiofrequency ablation for liver cancers. Br J Radiol, 2017, 27(9):63-67. [20]Kai L, Zhong ZS, Erjiao X, et al. Evaluation of the ablation margin of hepatocellular carcinoma using CEUS-CT/MR image fusion in a phantom model and in patients. Bmc Cancer, 2017, 17(1):61-70. |